Literature DB >> 6858711

Schneider's first rank symptoms of schizophrenia in Kenyan patients.

D M Ndetei, A Singh.   

Abstract

Eighty 'psychotic' patients admitted to Mathare Psychiatric Hospital, Nairobi, were screened using the New Haven Schizophrenic Index (NHSI). Fifty-one (64%) of these were positive and the rest negative. Of those positive 73% had First Rank Symptoms (FRS) of schizophrenia as opposed to only 24% in the group negative for schizophrenia. This difference is highly significant (P less than 0.001). The commonest individual FRS were thought echo, thought insertion, delusional mood and auditory hallucinations in third person. The frequency distribution of FRS had no relation to sex or age. These results are compared and contrasted with the findings of similar studies in various cultures.

Entities:  

Mesh:

Year:  1983        PMID: 6858711     DOI: 10.1111/j.1600-0447.1983.tb00335.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  4 in total

Review 1.  First rank symptoms for schizophrenia.

Authors:  Karla Soares-Weiser; Nicola Maayan; Hanna Bergman; Clare Davenport; Amanda J Kirkham; Sarah Grabowski; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-01-25

Review 2.  The diagnostic status of first-rank symptoms.

Authors:  Julie Nordgaard; Sidse M Arnfred; Peter Handest; Josef Parnas
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

3.  Schneider's first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis.

Authors:  Fernando R Malinowski; Brazilio de C Tasso; Bruno B Ortiz; Cinthia H Higuchi; Cristiano Noto; Sintia I Belangero; Rodrigo A Bressan; Ary Gadelha; Quirino Cordeiro
Journal:  Braz J Psychiatry       Date:  2020 Jan-Feb       Impact factor: 2.697

4.  Longitudinal Course of Illness in Congenitally Deaf Patient with Auditory Verbal Hallucination.

Authors:  Yoshihiro Matsumoto; Nobutaka Ayani; Yurinosuke Kitabayashi; Jin Narumoto
Journal:  Case Rep Psychiatry       Date:  2022-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.